Synovetin OA
Preclinical and rodent studies demonstrate disease
modification properties1,2
Tin-117m was shown to:1,2
- Substantially reduce synovitis in rodent models
- Significantly slow bony remodeling
“Histopathology indicates a disease modifying positive therapeutic effect in rodent models.”
—Dr. Alison Bendele, Senior Pathologist, DVM, PhD, DACVP
President & CEO, Inotiv, Inc. and study author
References:
1. Doerr C, Bendele A, Simon J, et al. Poster presented at the Society of Nuclear Medicine & Molecular Imaging Annual Conference. San Diego, CA. 2016.
2. Data on File. Pathology Report. Inotiv, Inc.; Boulder, CO.
Sign up to receive a link to the paper
“Evidence of osteoarthritis disease modification with a Sn-117m microparticle device: a review and validation in mammalian Models” when published in peer-reviewed Frontiers in Veterinary Science.